Results 21 to 30 of about 1,881 (198)

ATOSIBAN, PERSPECTIVAS SOBRE EL MANEJO ETIOLOGICO DEL PARTO PREMATURO

open access: yesRevista Chilena de Obstetricia y Ginecología, 2002
Analizamos la información disponible respecto del fármaco tocolítico atosiban para evaluar las ventajas y desventajas de esta droga en comparación con las drogas de primera línea, en cuanto a su acción inhibitoria rápida de las contracciones uterinas, su
Verónica Sáez R.   +2 more
doaj   +2 more sources

Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation

open access: yesBMC Pregnancy and Childbirth, 2009
Background The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment. Betamimetics are commonly
Connolly Mark, Wex Jaro, Rath Werner
doaj   +2 more sources

Critical appraisal and clinical utility of atosiban in the management of preterm labor

open access: yesTherapeutics and Clinical Risk Management, 2010
Olaleye Sanu1, Ronald F Lamont1–51Department of Obstetrics and Gynaecology, St Mary’s Imperial NHS Trust, London, UK; 2Northwick Park Institute of Medical Research, London, UK; 3Imperial College, London, UK; 4University College ...
Olaleye Sanu, Ronald F Lamont
doaj   +1 more source

Comparison of terbutaline and atosiban as tocolytic agents in intrauterine repair of myelomeningocele: a retrospective cohort study

open access: yesBrazilian Journal of Anesthesiology
Background: Myelomeningocele (MMC) is a neural tube defect disease. Antenatal repair of fetal MMC is an alternative to postnatal repair. Many agents can be used as tocolytics during the in utero fetal repair such as β2-agonists and oxytocin receptor ...
Shirley Andrade Santos   +11 more
doaj   +2 more sources

The effectiveness and safety of continuous and repeated treatment of atosiban in twin pregnancy with threatened preterm labor: A propensity score-matched study. [PDF]

open access: yesPLoS ONE
PurposeThis retrospective cohort study aimed to evaluate the effects and adverse outcomes of continuous and repeated treatment with atosiban in twin pregnancies with threatened preterm labor.Patients and methodsThe study was conducted at the Department ...
Hao Zhu, Weirong Gu, Bian Wang, Rong Hu
doaj   +2 more sources

Pregnancy and neonatal outcomes of hyperglycemia caused by atosiban administration during pregnancy

open access: yesClinical and Experimental Obstetrics & Gynecology, 2021
It is known that atosiban has fewer side effects than conventional tocolytics. In clinical practice, however, hyperglycemia can be commonly observed in mothers who have been administered atosiban.
Hyun Jin Ko   +2 more
doaj   +1 more source

Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis

open access: yesBMC Pregnancy and Childbirth, 2022
Background Worldwide, nifedipine and atosiban are the two most commonly used tocolytic agents for the treatment of threatened preterm birth. The aim of this study was to evaluate the effectiveness of nifedipine and atosiban in an individual participant ...
Tijn M. S. van Winden   +9 more
doaj   +1 more source

Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis

open access: yesFrontiers in Endocrinology, 2023
BackgroundRepeated embryo implantation failure (RIF) posed a significant challenge in assisted reproduction. Evidence of its therapeutic effectiveness including atosiban used around embryo transfer to improve pregnancy outcomes in RIF patients undergoing
Ruxin Wang   +6 more
doaj   +1 more source

Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor. [PDF]

open access: yes, 2020
OBJECTIVE:  The aim of this study is to assess the efficacy and safety of retosiban in spontaneous preterm labor (sPTL). STUDY DESIGN:  Two multicenter, randomized, and double-blind trials compared retosiban with placebo and retosiban with atosiban in ...
Montague, TH   +39 more
core   +1 more source

Prenatal exposure to antihypertensive medication: A systematic review of neurodevelopmental and educational outcomes. [PDF]

open access: yesJCPP Adv
This systematic review investigated the association of prenatal exposure to antihypertensive medication with longer‐term poor neurodevelopmental outcomes by evaluating the findings from existing literature. We undertook a systematic review of previous studies looking specifically at neurodevelopmental outcomes in children.
Alkhalaf S   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy